Meilleure Health Plans 10-Year Share Award Scheme to Align Stakeholder Interests

An announcement from Meilleure Health International Industry Group Limited ( (HK:2327) ) is now available.

Meilleure Health International Industry Group Limited plans to adopt a new 2026 Share Award Scheme, which will run for 10 years once approved and will be treated as a share scheme under Chapter 17 of the Hong Kong Listing Rules. The scheme is designed to encourage share ownership among eligible employees, service providers and related entities, helping to retain talent, incentivise performance and better align their interests with those of shareholders.

Implementation of the 2026 Share Award Scheme is conditional on shareholder approval at a special general meeting and the Stock Exchange’s listing approval for any new shares issued under the awards. The company will send a circular to shareholders in due course outlining the detailed terms of the scheme and the SGM notice, signalling a move to strengthen long-term incentives and potentially enhance corporate value and governance alignment.

The most recent analyst rating on (HK:2327) stock is a Hold with a HK$0.25 price target. To see the full list of analyst forecasts on Meilleure Health International Industry Group Limited stock, see the HK:2327 Stock Forecast page.

More about Meilleure Health International Industry Group Limited

Meilleure Health International Industry Group Limited is a Bermuda-incorporated company listed on the Main Board of the Hong Kong Stock Exchange under stock code 2327. The group operates through various subsidiaries and focuses on delivering products and services within its health-related business segments to a broad base of stakeholders in Hong Kong and beyond.

Average Trading Volume: 2,113,894

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.04B

Learn more about 2327 stock on TipRanks’ Stock Analysis page.